Talk:Naringin
This article is rated Start-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | |||||||||||||||||||||||||||||||
|
Structure
[edit]the structure is wrong. The 3-hydroxyl should be removed. --Kupirijo 17:54, 27 November 2006 (UTC)
WikiProject Food and drink Tagging
[edit]This article talk page was automatically added with {{WikiProject Food and drink}} banner as it falls under Category:Food or one of its subcategories. If you find this addition an error, Kindly undo the changes and update the inappropriate categories if needed. The bot was instructed to tagg these articles upon consenus from WikiProject Food and drink. You can find the related request for tagging here . Maximum and careful attention was done to avoid any wrongly tagging any categories , but mistakes may happen... If you have concerns , please inform on the project talk page -- TinucherianBot (talk) 06:45, 4 July 2008 (UTC)
Primary research
[edit]The following was removed from the article as preliminary research, WP:PRIMARY, too vague for its relevance to be included in the article. Please review WP:MEDRS for any inference to human biology. Thanks. --Zefr (talk) 01:52, 8 May 2017 (UTC)
- The research discussion provided below has been done with mice/rat models of obesity and diabetes and this has explicitly been stated several times in the preceding paragraphs. Much of the research presented here has been corroborated and confirmed by secondary research/reviews, unlike "preliminary" research. The lack of clinical/ human based trials has also been noted. Addition of these details to the original page will only enrich the knowledge since the primary focus of research on naringin is with regards to it's anti-oxidant/ anti-inflammatory properties. Without this information, knowledge of this compound is incomplete and I politely ask you to reconsider. Thank you. Shivali313 (talk) 03:55, 8 May 2017 (UTC)
- Wikipedia is not a textbook or journal review article needing all this preliminary research. See WP:NOTJOURNAL, numbers 6-8. Please do not add this content to the article. There are no WP:MEDRS-quality sources to support the sections below being included. If you disagree, you can seek arbitration at WT:MED. --Zefr (talk) 04:38, 8 May 2017 (UTC)
Diabetes
Insulin resistance and hyperglycemia are hallmarks of diabetes. Insulin resistance is defined as the lowered response of peripheral tissue cells to the hormone insulin. Inflammatory cytokines such as TNF-α and IL-6 have been indicated in the dysfunction of peripheral insulin receptors which disables them from recognizing insulin. This leads to increased insulin levels in blood which ultimately leads to increased glucose concentration in plasma. Co-treatment of Naringin and Vitamin C has shown to significantly improve insulin levels in rats. Naringin’s antioxidant and anti-inflammatory properties are derived from its ability to phosphorylate and activate AMPK≠, which under normal conditions is stimulated by the satiety hormone leptin to induce glucose metabolism. Lack of clinical trials conducted in this field makes its therapeutic effects on humans unclear.
Cardioprotective effects
Cardiac fibrosis, the thickening of heart valves, as well as cardiac remodelling often occur as a result of high-carbohydrate/high-fat (HCHF) induced diet. This has been experimentally proved even in animal models like rats where HCHF diets induce symptoms of metabolic syndrome including impaired glucose tolerance, excessive fat deposition, and proinflammatory markers. In the heart this led entry of inflammatory cells into the left ventricle, increased diastolic stiffness, and endothelial dysfunction along with other harmful changes to the cardiovascular changes. Due to it’s anti-inflammatory effects, naringin supplementation was shown to reduce inflammation and hypertrophy in the left ventricle of animals on a high-fat/high-carbohydrate diet. It further prevented cardiac remodelling in the hearts of these animals, improved oxidative stress and mitochondrial function, and reduced plasma lipids. Naringin’s cardiprotective quality comes from it’s ability to inhibit high glucose induced apoptosis by attenuating mitochondrial dysfunction and modulating the activation of p38 pathway, which is activated as a result of stress.
References